Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-224P is a pseudogene related to U6 small nuclear RNA (snRNA), which means it is a nonfunctional copy or derivative of the highly conserved U6 snRNA gene. U6 snRNA is essential for pre-mRNA splicing within the spliceosome, playing key roles by forming complex RNA-protein structures for intron removal. However, as a pseudogene, RNU6-224P does not produce functional RNA involved in splicing; it is a remnant sequence arising via duplication or retrotransposition, and is not known to encode a protein, participate in RNA regulation, or be involved in any disease or physiological process. There are no known aliases beyond the provided designations, no drugs that interact with it, and no described role as a biomarker or therapeutic target. If more specific structured data is published for this locus in future (e.g., regulatory RNA activity, ceRNA roles, or disease association), those would warrant updating the above assignments. Currently, it is a non-coding, non-target pseudogene.
Null (not a therapeutic target, so no mechanisms of drug action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 224, pseudogene (RNU6-224P).